First Product. Xxxxxx shall make each of the following non-refundable, non-creditable payments to Enanta within thirty (30) days after the occurrence of each of the following milestone events for the first Candidate or Product, as the case may be, that is not a Co-Developed Product (the “Initial Product”): Milestone Event Milestone Payment Successful Completion of Phase Ib/IIa Clinical Study $ 40 million Initiation of first Phase III Clinical Trial $ 15 million [*****] [***** ] [*****] [***** ] [*****] [***** ] [*****] [***** ] [*****] [***** ]
Appears in 2 contracts
Samples: Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc), Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)
First Product. Xxxxxx shall make each of the following non-refundable, non-creditable payments to Enanta within thirty (30) days after the occurrence of each of the following milestone events for the first Candidate or Product, as the case may be, that is not a Co-Developed Product (the “Initial Product”): Milestone Event Milestone Payment Successful Completion of Phase Ib/IIa Clinical Study $ $40 million Initiation of first Phase III Clinical Trial $ 15 million [*****] [***** *] [*****] [***** *] [*****] [***** *] [*****] [***** *] [*****] [***** *] [*****] [*****]
Appears in 2 contracts
Samples: License Agreement, Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)
